Jan 15, 2025, 08:41 AM by

DoseMe, a leader in model-informed precision dosing (MIPD), announced the University Medical Centre Ljubljana and University Hospital of Maribor have implemented DoseMeRx, an innovative therapeutic drug monitoring (TDM) platform. This marks a significant advancement in antimicrobial stewardship in Slovenia.

Jan 15, 2025, 01:00 AM by User Not Found

Bio-IT World | Gordon Sanghera, CEO, presented on behalf of Oxford Nanopore Technologies at the 43rd Annual J.P. Morgan Healthcare Conference this week in San Francisco. Sanghera led the major sequencing companies in position on the program, presenting on Monday a multi-omics and proteomics emphasis that was echoed throughout the week by other sequencing platform providers.

Jan 14, 2025, 08:17 AM by

Record year comes as the rise of precision medicine drives a surge in demand

Jan 14, 2025, 08:17 AM by

Ajay Gannerkote, an experienced healthcare leader with more than 20 years of demonstrated success driving industry growth and transformation, takes helm at global genomics company

Jan 14, 2025, 01:00 AM by User Not Found

Bio-IT World | An international team of researchers is delving into the molecular and cellular changes in muscle tissue associated with Chronic Fatigue Syndrome (CFS) and long COVID. The effort focuses on identifying biomarkers and pathways that could pave the way for diagnosis and treatment.

Jan 13, 2025, 09:00 AM by User Not Found

Bio-IT World | Among the many partnerships and technical announcements made by NVIDIA during the company's Monday morning presentation at the 43rd Annual J.P. Morgan Healthcare Conference, NVIDIA focused several on innovation within the healthcare and life sciences industry.

Jan 13, 2025, 08:15 AM by

Collaboration combines Owkin’s novel AI target discovery and agentic AI expertise with Absci’s leading AI de novo design models to accelerate the discovery and design of potential first-in-class therapeutics

Jan 13, 2025, 08:15 AM by

Chromatin Bioscience is pleased to announce its ongoing collaboration with EsoBiotec, which has successfully advanced its ESO-T01 in vivo CAR-T candidate into clinical trials. ESO-T01 is the first in vivo B-cell maturation antigen (BCMA) CAR-T candidate to reach the clinical stage and utilises a synthetic promoter designed using Chromatin Bio’s proprietary promoter design platform, chromatinLENS, exclusively for EsoBiotec as part of its innovative approach to immunotherapy.

Jan 10, 2025, 08:28 AM by

Coronado Research is pleased to announce the appointment of Jo Marshall as EVP of Data Services and Advanced Analytics.

Jan 10, 2025, 08:28 AM by

Jan 10, 2025, 08:28 AM by

STEMart introduces Balloon Catheter Testing Services for the development of safe and effective medical devices.

Jan 10, 2025, 08:28 AM by

Biofidelity and CellCarta have announced a strategic partnership agreement to utilize Biofidelity’s Aspyre® Lung in global clinical trials.

Jan 9, 2025, 08:35 AM by

Bio-IT World Conference & Expo, the premier annual gathering of 3,000 innovators at the intersection of IT and life sciences, returns to Boston April 2-4, ready to meet participants’ demand for the latest information on cutting-edge technologies like generative AI, machine learning (ML), and quantum computing that promise to shape precision medicine and redefine patient outcomes.

Jan 9, 2025, 08:35 AM by

ThirdLaw Molecular Inc., a targeted drug discovery biotech reimagining molecular therapeutics, today announced the launch of its first DNA-encoded library of 4.5 billion Spiroligomer™ macromolecules. This library provides the Company and prospective partners access to a revolutionary category of molecules and the potential to transform how diseases are diagnosed and treated

Jan 9, 2025, 08:35 AM by

Leica Biosystems and Indica Labs today announced that Leica Biosystems has agreed to make a significant strategic investment in Indica Labs.

Jan 9, 2025, 01:00 AM by User Not Found

Bio-IT World | Looming uncertainties tied to the upcoming U.S. administration change will affect many key areas of artificial intelligence (AI) in 2025, according to Mark Dredze, interim deputy director for the Data Science and AI Institute at Johns Hopkins University. While a focus on deregulation appears likely, exactly how things will play out for AI governance and policy is anyone’s guess.

Jan 8, 2025, 07:53 AM by

Following an expanded collaboration between AI innovator Quris-AI and Merck KGaA and a two-year validation study to test clinical safety prediction by identifying drug candidate liver toxicity risks, it was announced this morning that Merck KGaA has adopted the startup's platform to test small molecule drug candidates prior to initiating clinical trials. Quris-AI’s platform integrates advanced AI, machine learning, generative models, patient-on-chip technology, and proprietary data to predict potential drug-induced toxicities better.

Jan 8, 2025, 07:53 AM by

ClearNote Health announced that its Avantect Multi-Cancer Detection Test was selected for the National Cancer Institute’s new Vanguard Study.

Jan 8, 2025, 01:00 AM by User Not Found

Bio-IT World | The placenta is a temporary but critical organ everyone needs to initiate their life, yet it remains one of the most understudied organs in human biology despite the possible lifelong health implications if anything it is supposed to do goes awry.

Jan 7, 2025, 01:00 AM by User Not Found

Bio-IT World | 2024 was full of innovative ideas and achievements. We spoke with industry experts and leaders about what to anticipate in the new year. Here are the full trends and predictions, including more on AI/ML, multimodal data, drug discovery, new policies, spatial biology, and more.